Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma

• Published in: Cell death & disease Vol. 4; no. 5; p. e634
• Main Authors: Yu, X, Zhen, Y, Yang, H, Wang, H, Zhou, Y, Wang, E, Marincola, F M, Mai, C, Chen, Y, Wei, H, Song, Y, Lyu, X, Ye, Y, Cai, L, Wu, Q, Zhao, M, Hua, S, Fu, Q, Zhang, Y, Yao, K, Liu, Z, Li, X, Fang, W
• Format: Journal Article
• Language: English
• Published: England Springer Nature B.V 01.05.2013; Nature Publishing Group
• Subjects: Animals; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Connective Tissue Growth Factor - antagonists & inhibitors; Connective Tissue Growth Factor - genetics; Connective Tissue Growth Factor - metabolism; Down-Regulation; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs - metabolism; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms - metabolism; Nasopharyngeal Neoplasms - pathology; Original; Phosphatidylinositol 3-Kinases - genetics; Phosphatidylinositol 3-Kinases - metabolism; Prognosis; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt - genetics; Proto-Oncogene Proteins c-akt - metabolism; Proto-Oncogene Proteins c-jun - metabolism; Proto-Oncogene Proteins c-myc - metabolism; RNA Interference; RNA, Small Interfering - metabolism; Transplantation, Heterologous
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/cddis.2013.153

Connective tissue growth factor (CTGF) has different roles in different types of cancer. However, the involvement and molecular basis of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC) have almost never been reported. In this study, we observed that downregulated CTGF expression was significantly associated with NPC progression and poor prognosis. Knockdown of CTGF markedly elevated the ability of cell proliferation in vivo and in vitro. Subsequently, we discovered that the reduction of CTGF increased the expression of miR-18b, an oncomir-promoting cell proliferation. Further, we discovered that attenuated CTGF-mediated upregulation of miR-18b was dependent on the increased binding of transcription factors Jun proto-oncogene (C-Jun) and v-Myc myelocytomatosis viral oncogene homolog (C-Myc) to miR-18b promoter region via phosphoinositide 3-kinase (PI3K)/AKT pathway. Finally, we further found that miR-18b directly suppressed the expression of CTGF in NPC. In clinical fresh specimens, miR-18b was widely overexpressed and inversely correlated with CTGF expression in NPC. Our studies are the first to demonstrate that reduced CTGF as an unfavorable prognosis factor mediates the activation of miR-18b, an oncomir directly suppresses CTGF expression, by PI3K/AKT/C-Jun and C-Myc and promotes cell growth of NPC.